SARAH HIRSCHMAN: Open Payments
NPI 1629491113 · MT PLEASANT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,085 in 177 payments from 20 companies in 2025. Trend: 2023 $3,137 · 2024 $3,118 · 2025 $3,085
Food & beverage: $2,867Education: $218
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $441 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 20 | $315 |
| GENZYME CORPORATION | 9 | $304 |
| Novartis Pharmaceuticals Corporation | 28 | $281 |
| Janssen Biotech, Inc. | 5 | $262 |
| Regeneron Healthcare Solutions, Inc. | 6 | $224 |
| Galderma Laboratories, L.P. | 20 | $215 |
| E.R. Squibb & Sons, L.L.C. | 14 | $204 |
| UCB, Inc. | 8 | $187 |
| Incyte Corporation | 9 | $151 |
Products named: DUPIXENT, COSENTYX, TREMFYA, RINVOQ, ILUMYA, Sotyktu, Bimzelx, NEMLUVIO.
Industry payments across MI — which companies pay providers there.
